Preparation method of medical dressing containing copper ions
By using the polyurethane foam layer to adsorb copper ions and form an interwoven network in medical dressings, the existing dressings have insufficient antibacterial performance and allergic problems have been solved, and high-strength, long-term antibacterial and wound healing effects have been achieved.
Patent Information
- Application Number
- CN202411263761.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-10
- Publication Date
- 2024-12-06
AI Technical Summary
The existing medical dressings have insufficient antibacterial properties, which can easily cause skin allergies and cannot effectively promote wound healing.
The polyurethane foam layer is used to adsorb copper ions, and an interwoven network is formed by adhering to glutamic acid solution and hydroxyapatite nanowires to block the contact between copper ions and skin, and the positive and negative charges are used to attract copper ions to gradually release them to the wound, combining with the polymerization of the caustic acid Ester-modified chitosan fibers and pore-forming agents improve the flow diversion effect of copper ions.
It achieves a high-intensity and long-acting antibacterial effect, reduces skin sensitivity, promotes wound healing, and controls the occurrence of scars.
Smart Images

Figure BDA0005036557790000091 
Figure BDA0005036557790000101
Abstract
Description
Technical Field
[0001] The present application relates to the field of medical dressings, and more specifically, to a method for preparing a medical dressing containing copper ions. Background Art
[0002] With the continuous development of medical technology, people's requirements for wound dressings are getting higher and higher. Although traditional dressings such as gauze and bandages have a certain protective effect, their antibacterial properties are limited and they cannot effectively prevent wound infection.
[0003] Currently, antibacterial dressings include silver ion dressings, iodine tincture dressings, etc. However, although silver ion dressings have certain antibacterial effects, the duration of antibacterial activity is not high enough, and after silver ion dressings come into contact with the skin, they are prone to adverse reactions such as skin discoloration and allergies. The antibacterial properties of iodine tincture dressings are not only not strong enough but also not long-lasting, and iodine tincture dressings have little effect on wound healing.
[0004] Therefore, how to prepare a new medical dressing that has a strong and long-lasting antibacterial effect, is not prone to causing allergic symptoms, and can promote wound healing is a problem to be solved. Summary of the invention
[0005] In order to prepare a new medical dressing that has a high-strength and long-lasting antibacterial effect, is not prone to causing allergic symptoms, and can promote wound healing, the present application provides a method for preparing a medical dressing containing copper ions.
[0006] The present application provides a method for preparing a medical dressing containing copper ions, which adopts the following technical scheme: A method for preparing a medical dressing containing copper ions comprises the following steps: S1. Evenly spray adhesive on the surface of the polyurethane film to obtain an adhesive layer; S2, immersing the polyurethane foam layer in a copper citrate solution, then taking out the polyurethane foam layer, and freeze-drying it to obtain an adsorption layer; S3, bonding one side of the adsorption layer to the surface of the adhesive layer, spraying glutamic acid solution evenly on the other side of the adsorption layer, and then bonding the hydroxyapatite nanowires, and finally pasting the release paper, drying, sterilizing, and obtaining a medical dressing.
[0007] By adopting the above technical scheme, the good adsorption effect of the polyurethane foam layer is utilized to facilitate the adsorption of the copper citrate solution, so that the polyurethane foam layer is loaded with a higher content of copper ions; the polyurethane foam layer adsorbed with copper ions is bonded to the surface of the adhesive layer, and the side of the polyurethane foam layer surface in contact with the skin is adhered to the glutamic acid solution and the hydroxyapatite nanowires, and the viscosity of the glutamic acid solution is utilized to facilitate the adhesion of the hydroxyapatite nanowires to the surface of the polyurethane foam layer, the glutamic acid solution contains amino and carboxyl groups, and the hydroxyapatite nanowires are bonded to the glutamic acid solution to form an interwoven network.
[0008] The dressing is applied on the skin surface, and the hydroxyapatite nanowires are in direct contact with the skin. By blocking a large amount of copper ions in the polyurethane foam layer from direct contact with the skin, the irritating effect of copper ions on the skin surface is reduced. The copper ions in the polyurethane foam layer are positively charged, glutamic acid is negatively charged, and the hydroxyapatite nanowires are also negatively charged. By utilizing the attraction effect of positive and negative charges, the positively charged copper ions are gradually adsorbed in the interwoven network of glutamic acid and hydroxyapatite nanowires, so that the copper ions gradually reach the surface of the skin wound. The hydroxyapatite nanowires are non-irritating on the skin surface, and the slow release of copper ions not only makes the skin less sensitive, but also copper ions can stimulate cell proliferation and differentiation, and promote wound healing. At the same time, copper ions have a broad-spectrum antibacterial effect, can kill and inhibit a variety of bacteria, and have a long action time; thus, the dressing has a high-strength and long-lasting antibacterial effect, is not easy to cause allergic symptoms, and can promote wound healing.
[0009] When the wound is scratched, the medical dressing acts on the wound surface. As the wound tissue fluid flows out, the adsorption effect of hydroxyapatite nanowires and glutamic acid is used to facilitate the tissue fluid to reach the surface of the polyurethane foam layer. The polyurethane foam layer is used to adsorb the tissue fluid, and the bacteria adsorbed along with the tissue fluid at the wound can be killed by the copper ions in the polyurethane foam layer, and the killed bacteria are stably adsorbed in the polyurethane foam layer; the bacterial surface is negatively charged, and the copper ions can stably adsorb the bacteria, making it difficult for the bacteria to flow back to the wound surface and cause infection problems; and even if the glutamate solution gradually dissolves due to the water in the tissue fluid, causing the hydroxyapatite nanowires to gradually contact the deep part of the wound, the hydroxyapatite nanowires have good biocompatibility and bone conductivity, which is convenient for guiding copper ions to reach the deep part of the wound. The bactericidal effect of copper ions is used to facilitate the removal of bacteria deep in the wound, and promote the reproduction of fibroblasts deep in the wound, promote wound healing, and minimize the formation of scars.
[0010] Preferably, the polyurethane foam layer comprises the following raw materials in parts by weight: 80-100 parts of waterborne polyurethane prepolymer, 20-30 parts of isocyanate, 2-5 parts of foaming agent, 1-5 parts of polycaprolactone modified chitosan fiber, 2-8 parts of surfactant, 1-3 parts of pore-forming agent and 100-240 parts of water.
[0011] By adopting the above technical scheme, after the waterborne polyurethane prepolymer is cross-linked with isocyanate, a porous and stable polyurethane foam layer can be obtained under the action of a foaming agent and a pore-forming agent. Under the action of a surfactant and polycaprolactone-modified chitosan fiber, copper ions and wound tissue fluid can be easily adsorbed, so that the dressing has the advantage of slowly releasing copper ions, can have long-term antibacterial effect, and can also promote wound healing.
[0012] When the dressing acts on the wound surface, it utilizes the combination of polycaprolactone-modified chitosan fibers and copper ions, the repulsion between the positive charge of chitosan fibers and the positive charge of copper ions, the diversion effect of tissue fluid, and the negative charge adsorption effect of glutamate and hydroxyapatite nanowires, to facilitate the gradual migration of copper ions toward the wound surface, and exert the effect of antibacterial and promoting wound healing.
[0013] Preferably, the polycaprolactone modified chitosan fiber is prepared by the following method: The polycaprolactone solution is weighed at a mass ratio of 1:1.5-2.5 and sprayed uniformly on the surface of the chitosan fiber, and then dispersed and dried to obtain a finished product.
[0014] By adopting the above technical scheme, the chitosan fiber treated with polycaprolactone can make the burrs on the surface of the chitosan fiber smooth by limiting the ratio, provide a diversion effect for the migration and movement of copper ions, and is not easy to over-bind copper ions, resulting in the copper ions being unable to reach the surface of the hydroxyapatite nanowires and contacting the skin; and polycaprolactone will not block the charge effect between the chitosan fiber and the copper ions, and can still promote the migration and movement of copper ions toward the skin surface, ensuring the antibacterial and bactericidal effects of copper ions on the skin surface; at the same time, by limiting the ratio of polycaprolactone and chitosan fiber, the cross-linking degree between the polycaprolactone-modified chitosan fiber and the polyurethane is better, the chitosan fiber is stably dispersed in the polyurethane foam layer, the porosity of the polyurethane foam layer is ensured while adsorbing tissue fluid and bacteria, and the release of copper ions can be ensured, so that the medical dressing has the advantages of long-term antibacterial and antibacterial, and can also promote wound healing, and is not prone to the problem of bacteria causing skin sensitivity.
[0015] Preferably, the pore-forming agent is prepared by the following method: Polyethylene glycol ethanol solution is uniformly sprayed on the surface of chitosan quaternary ammonium salt particles, then sodium bicarbonate particles are bonded, and then dried and dispersed to prepare a pore-forming agent; the mass ratio of chitosan quaternary ammonium salt particles to polyethylene glycol ethanol solution and sodium bicarbonate particles is 1:0.2-0.4:0.5-1.
[0016] By adopting the above technical scheme, sodium bicarbonate particles are bonded to the surface of chitosan quaternary ammonium salt particles using polyethylene glycol ethanol solution to prepare a pore-forming agent. Sodium bicarbonate is insoluble in ethanol and does not affect the thermal decomposition pore-forming effect of sodium bicarbonate in the process of preparing the polyurethane foam layer. The generated carbon dioxide gas further increases the porosity of the polyurethane foam layer. Sodium bicarbonate begins to decompose at 50° C. to produce sodium carbonate and carbon dioxide gas. Sodium carbonate can be filled in the polyurethane foam layer to maintain an alkaline environment. Under alkaline conditions, chitosan quaternary ammonium salt and chitosan fibers are positively charged, which repel the positive charge of copper ions. During the use of the dressing, copper ions are easy to migrate toward the skin surface under the diversion effect of fibers and pores, thereby achieving the antibacterial and bactericidal effect on the skin surface, ensuring the long-term bactericidal and antibacterial effects of the dressing, and not easy to irritate the skin.
[0017] Preferably, the glutamate solution is composed of a glutamate aqueous solution and a sodium alginate solution in a mass ratio of 1:0.1-0.2.
[0018] By adopting the above technical scheme, the glutamic acid aqueous solution and the sodium alginate solution are matched, and the viscosity of the sodium alginate solution is used to improve the viscosity of the glutamic acid solution, so that the hydroxyapatite nanowires are easily adhered to the surface of the polyurethane foam layer. Glutamic acid contains amino and carboxyl groups, and sodium alginate contains carboxyl groups. Combined with the flexible folding effect and hydroxyl groups of the hydroxyapatite nanowires, an interwoven network is easily formed on the surface of the polyurethane foam layer. The glutamic acid, sodium alginate and hydroxyapatite nanowires in the interwoven network have no irritating effect on the skin surface, and are not prone to allergic reactions after contact with the skin. In addition, the negative charges in the interwoven network can gradually cause copper ions to migrate toward the interwoven network. The copper ions are highly stable in the interwoven network and are not easy to irritate the skin. They can effectively and for a long time exert bactericidal and antibacterial effects on the skin surface, and can also promote wound healing.
[0019] If the dressing is used on a wound where tissue fluid and blood have overflowed, as the tissue fluid and blood are absorbed, the presence of water will tend to cause glutamate and sodium alginate to gradually dissolve. Although the dissolved glutamate solution can adhere the interwoven network to the surface of the polyurethane foam layer, it is also easy for the ends of some hydroxyapatite nanowires to separate from the polyurethane foam layer. After one end of the hydroxyapatite nanowire carrying copper ions enters deep into the wound, it can further achieve bactericidal and antibacterial effects deep in the wound, promote wound healing, reduce the probability of forming scars in deep wounds, and is less likely to cause skin sensitivity problems.
[0020] Preferably, the hydroxyapatite nanowires are prepared by soaking hydroxyapatite nanowire filaments in a citric acid solution and then drying them.
[0021] By adopting the above technical solution, hydroxyapatite nanowires have good flexibility. After being treated with citric acid solution, the negative charge content can be increased, thereby facilitating the adsorption of copper ions to reach the skin surface. Combined with the carboxyl group in citric acid, the stability and adsorption effect of the interwoven network are further improved, which is convenient for adsorbing tissue fluid while achieving antibacterial and bactericidal effects, thereby improving the long-term antibacterial effect of the dressing, promoting wound healing while minimizing the problem of wound infection.
[0022] Preferably, the adhesive in S1 is a silicone adhesive.
[0023] By adopting the above technical solution, the silicone adhesive has a good bonding effect and a certain air permeability, thereby ensuring the oxygen exchange effect and promoting wound healing.
[0024] Preferably, the copper citrate solution in S2 is a copper citrate aqueous solution with a mass fraction of 1-8%.
[0025] Preferably, the pressure of the immersion treatment in S2 is 0.2-0.5 MPa.
[0026] By adopting the above technical scheme, the content and immersion pressure of the copper citrate aqueous solution are limited, and the loading effect of the polyurethane foam layer on copper ions is ensured, thereby achieving the slow release of copper ions in the dressing, allowing the dressing to exert its antibacterial and bactericidal effects for a long time and promote wound healing.
[0027] Preferably, the freeze-drying temperature in S2 is -40°C to -20°C, and the freeze-drying time is 12-24h.
[0028] By adopting the above technical scheme, the freeze-drying temperature and time are limited to ensure that the polyurethane foam layer has a higher porosity after being loaded with copper ions. It can absorb tissue fluid while ensuring the slow release of copper ions, thereby extending the antibacterial and bactericidal effect of the dressing, promoting wound healing, and reducing the formation of scars.
[0029] In summary, this application has the following beneficial effects: 1. The polyurethane foam layer is used to absorb copper ions. The side of the polyurethane foam layer that contacts the skin adheres to an interwoven network formed by glutamic acid solution and hydroxyapatite nanowires. The interwoven network is used as a spacer to ensure that the skin will not be sensitive to copper ions during the use of the dressing. The copper ions can also exert a long-term, high-intensity antibacterial effect and promote wound healing.
[0030] 2. In the polyurethane foam layer, polycaprolactone-modified chitosan fibers and copper ions are combined, and the repulsion between the positive charge of chitosan fibers and the positive charge of copper ions is combined with the diversion effect of tissue fluid, as well as the negative charge adsorption effect of glutamic acid and hydroxyapatite nanowires. This facilitates the gradual migration of copper ions toward the wound surface, and exerts an antibacterial effect and promotes wound healing.
[0031] 3. The combination of copper ions, hydroxyapatite nanowires and glutamic acid solution makes the dressing have a better scar control effect. DETAILED DESCRIPTION
[0032] The present application is further described in detail below with reference to the embodiments.
[0033] Preparation example of polycaprolactone modified chitosan fiber The following raw materials are all commercially available.
[0034] Preparation Example 1: Polycaprolactone modified chitosan fiber is prepared by the following method: Weigh 1 kg of polycaprolactone solution and spray it evenly on the surface of 2 kg of chitosan fibers. The polycaprolactone solution is a 2% by mass polycaprolactone ethanol solution, the weight average molecular weight of polycaprolactone is 50,000 DA, the mass fraction of ethanol is 99%, the average length of the chitosan fibers is 20 μm, and the average diameter is 10 nm. The chitosan fibers are dispersed until they do not stick to each other and agglomerate, and then dried to obtain a finished product.
[0035] Preparation Example 2: This preparation example differs from Preparation Example 1 in that: Weigh 1 kg of polycaprolactone solution and spray it evenly on the surface of 1.5 kg of chitosan fiber. The polycaprolactone solution is a 2% by mass polycaprolactone ethanol solution, the weight average molecular weight of polycaprolactone is 50,000 DA, the mass fraction of ethanol is 99%, the average length of the chitosan fiber is 20 μm, and the average diameter is 10 nm. The chitosan fibers are dispersed until they do not stick to each other and agglomerate, and then dried to obtain a finished product.
[0036] Preparation Example 3: This preparation example differs from Preparation Example 1 in that: Weigh 1 kg of polycaprolactone solution and spray it evenly on the surface of 2.5 kg of chitosan fibers. The polycaprolactone solution is a 2% by mass polycaprolactone ethanol solution, the weight average molecular weight of polycaprolactone is 50,000 DA, the mass fraction of ethanol is 99%, the average length of the chitosan fibers is 20 μm, and the average diameter is 10 nm. The chitosan fibers are dispersed until they do not stick to each other and agglomerate, and then dried to obtain a finished product.
[0037] Preparation example of pore former The following raw materials are all commercially available.
[0038] Preparation Example 4: The pore-forming agent is prepared by the following method: 0.3 kg of polyethylene glycol ethanol solution is uniformly sprayed on the surface of 1 kg of chitosan quaternary ammonium salt particles, and then 0.8 kg of sodium bicarbonate particles are bonded, and the particles are dried and dispersed to prepare a pore-forming agent. The average particle size of the chitosan quaternary ammonium salt particles is 12 μm, the mass fraction of the polyethylene glycol ethanol solution is 10%, the polyethylene glycol is polyethylene glycol 8000, the mass fraction of ethanol is 99%, the average particle size of the sodium bicarbonate particles is 4 μm, and the pore-forming agent passes through a 600-mesh sieve.
[0039] Preparation Example 5: This preparation example differs from Preparation Example 4 in that: 0.2 kg of polyethylene glycol ethanol solution was uniformly sprayed on the surface of 1 kg of chitosan quaternary ammonium salt particles, and then 0.5 kg of sodium bicarbonate particles were bonded, and the particles were dried and dispersed to prepare a pore-forming agent.
[0040] Preparation Example 6: This preparation example differs from Preparation Example 4 in that: 0.4 kg of polyethylene glycol ethanol solution was uniformly sprayed on the surface of 1 kg of chitosan quaternary ammonium salt particles, and then 1 kg of sodium bicarbonate particles were bonded, and then dried and dispersed to prepare a pore-forming agent.
[0041] Preparation Example of Polyurethane Foam Layer Among the following raw materials, the waterborne polyurethane prepolymer was purchased from Hubei Langbowan Biopharmaceutical Co., Ltd., CAS No. 103837-45-2; other raw materials are all commercially available.
[0042] Preparation Example 7: The polyurethane foam layer is prepared by the following method: Weigh 90 kg of waterborne polyurethane prepolymer, 25 kg of isocyanate, 4 kg of blowing agent, 3 kg of polycaprolactone-modified chitosan fiber, 5 kg of surfactant, 2 kg of pore-forming agent, and 180 kg of water; the isocyanate is hexamethylene diisocyanate; the blowing agent is n-hexane, the polycaprolactone-modified chitosan fiber is the polycaprolactone-modified chitosan fiber prepared in Preparation Example 1, the surfactant is composed of sodium dodecylbenzene sulfonate and zinc stearate in a mass ratio of 2:1; the pore-forming agent is prepared Example 4 Preparation of pore-forming agent: After mixing water-based polyurethane prepolymer, foaming agent, polycaprolactone modified chitosan fiber, surfactant, pore-forming agent and water, stir at a speed of 1000r / min for 5min, then add isocyanate and continue stirring for 3min, then place in a foaming mold, foam at 80℃ for 20min, then heat to 100℃ and foam for 10min, finally demold and cut to obtain a polyurethane foam layer, the average thickness of the polyurethane foam layer is 2mm.
[0043] Preparation Example 8: This preparation example differs from Preparation Example 7 in that: Weigh 80kg of waterborne polyurethane prepolymer, 20kg of isocyanate, 2kg of foaming agent, 1kg of polycaprolactone-modified chitosan fiber, 2kg of surfactant, 1kg of pore-forming agent, and 100kg of water; the polycaprolactone-modified chitosan fiber is the polycaprolactone-modified chitosan fiber prepared in Preparation Example 2; the pore-forming agent is the pore-forming agent prepared in Preparation Example 5.
[0044] Preparation Example 9: This preparation example differs from Preparation Example 7 in that: Weigh 100kg of waterborne polyurethane prepolymer, 30kg of isocyanate, 5kg of foaming agent, 5kg of polycaprolactone-modified chitosan fiber, 8kg of surfactant, 3kg of pore-forming agent, and 240kg of water; the polycaprolactone-modified chitosan fiber is the polycaprolactone-modified chitosan fiber prepared in Preparation Example 3; the pore-forming agent is the pore-forming agent prepared in Preparation Example 6.
[0045] Preparation example of hydroxyapatite nanowires The hydroxyapatite nanowire filaments in the following raw materials were purchased from Wuhan Kemik Biomedical Technology Co., Ltd.; other raw materials were all commercially available.
[0046] Preparation Example 10: Hydroxyapatite nanowires are prepared by the following method: 1 kg of hydroxyapatite nanowire filaments were weighed and immersed in 10 kg of citric acid solution, ultrasonically dispersed at 20 kHz for 10 minutes, and then dried and dispersed until the hydroxyapatite nanowire filaments did not stick to each other and agglomerate to obtain a finished product; the average length of the hydroxyapatite nanowire filaments was 100 μm, the average diameter was 10 nm, and the citric acid solution was a citric acid aqueous solution with a mass fraction of 2%. Example
[0047] The polyurethane film among the following raw materials was purchased from the medical polyurethane breathable film produced by Hebei Weisai New Materials Technology Co., Ltd., with a thickness of 80 μm; the silicone adhesive was purchased from the medical Wacker silicone adhesive E41 from Shenzhen Longlifeng Materials Co., Ltd.; copper citrate was purchased from Wuhan Lanabai Pharmaceutical Chemical Co., Ltd., pharmaceutical grade; glutamic acid was purchased from Wuhan Lanabai Pharmaceutical Chemical Co., Ltd. as L-glutamic acid; other raw materials are all commonly available on the market.
[0048] Example 1: A method for preparing a medical dressing containing copper ions: S1. Spray adhesive evenly on the surface of the polyurethane film, 100 mL of adhesive per square meter of the polyurethane film surface, to obtain an adhesion layer; the adhesive is a silicone adhesive; S2, the polyurethane foam layer prepared in Preparation Example 7 is immersed in a copper citrate solution, the polyurethane foam layer is completely infiltrated in the copper citrate solution, and the copper citrate solution is a copper citrate aqueous solution with a mass fraction of 5%; the immersion treatment is carried out under an immersion pressure of 0.3 MPa for 20 minutes, and then the polyurethane foam layer is taken out and freeze-dried, the freeze-drying temperature is -40°C, and the freeze-drying time is 24 hours to obtain an adsorption layer; S3. Cut the adhesion layer according to the size of the adsorption layer. Both the adsorption layer and the adhesion layer are square, and the side length of the adhesion layer is 1.5 times that of the side length of the adsorption layer. Bond one side of the adsorption layer to the surface of the adhesion layer, and evenly spray glutamate solution on the surface of the adsorption layer away from the adhesion layer. Spray 0.5 mL of glutamate solution on 1 square centimeter of the adsorption layer surface. The glutamate solution consists of a glutamate aqueous solution and a sodium alginate solution in a mass ratio of 1:0.2. The glutamate aqueous solution is a 5% L-glutamate aqueous solution, and the sodium alginate solution is a 1% sodium alginate aqueous solution. Then, add the hydroxyapatite nanowires prepared in Preparation Example 10. The hydroxyapatite nanowires are evenly spread on the surface of the glutamate solution on the adsorption layer. The weight ratio of the glutamate solution and the hydroxyapatite nanowires is 1:1. Then, attach the release paper. The release paper can be completely attached to the surface of the adhesion layer. After drying, sterilize to obtain a medical dressing with an average thickness of 4 mm. During use, peel off the release paper and adhere the dressing to the wound surface.
[0049] Embodiment 2: This embodiment differs from Embodiment 1 in that: S2, the polyurethane foam layer prepared in Preparation Example 8 is immersed in a copper citrate solution, the polyurethane foam layer is completely infiltrated in the copper citrate solution, and the copper citrate solution is a copper citrate aqueous solution with a mass fraction of 1%; the immersion treatment is carried out under an immersion pressure of 0.2MPa for 20min, and then the polyurethane foam layer is taken out and freeze-dried, the freeze-drying temperature is -20°C, and the freeze-drying time is 24h, to obtain an adsorption layer; The glutamate solution in S3 is composed of a glutamate aqueous solution and a sodium alginate solution in a mass ratio of 1:0.1.
[0050] Embodiment 3: This embodiment differs from Embodiment 1 in that: S2. The polyurethane foam layer prepared in Preparation Example 9 is immersed in a copper citrate solution, wherein the polyurethane foam layer is completely soaked in the copper citrate solution, and the copper citrate solution is an aqueous copper citrate solution with a mass fraction of 8%; the polyurethane foam layer is immersed in the solution for 20 minutes under an immersion pressure of 0.5 MPa, and then the polyurethane foam layer is taken out and freeze-dried at a freeze-drying temperature of -40°C and a freeze-drying time of 12 hours to obtain an adsorption layer.
[0051] Embodiment 4: This embodiment differs from Embodiment 1 in that: No polycaprolactone-modified chitosan fiber was added during the preparation of the polyurethane foam layer.
[0052] Embodiment 5: This embodiment differs from Embodiment 1 in that: When preparing the polycaprolactone-modified chitosan fibers in the polyurethane foam layer, the chitosan fibers are replaced by glass fibers of equal mass.
[0053] Embodiment 6: This embodiment differs from Embodiment 1 in that: No pore former was added during the preparation of the polyurethane foam layer.
[0054] Embodiment 7: This embodiment differs from Embodiment 1 in that: The pore-forming agent in the polyurethane foam layer is sodium bicarbonate particles.
[0055] Embodiment 8: This embodiment differs from Embodiment 1 in that: No sodium alginate solution was added to the glutamate solution.
[0056] Embodiment 9: This embodiment differs from Embodiment 1 in that: The hydroxyapatite nanowires were not soaked in citric acid solution during the preparation process.
[0057] Comparative Example Comparative Example 1: The difference between this comparative example and Example 1 is that: S2, the polyurethane foam layer prepared in Preparation Example 7 is immersed in a copper citrate solution, the polyurethane foam layer is completely infiltrated in the copper citrate solution, and the copper citrate solution is a copper citrate aqueous solution with a mass fraction of 5%; the immersion treatment is carried out under an immersion pressure of 0.3 MPa for 20 minutes, and then the polyurethane foam layer is taken out and freeze-dried, the freeze-drying temperature is -40°C, and the freeze-drying time is 24 hours to obtain an adsorption layer; S3. Cut the adhesive layer according to the size of the adsorption layer. Both the adsorption layer and the adhesive layer are square. The side length of the adhesive layer is 1.5 times that of the adsorption layer. Bond one side of the adsorption layer to the surface of the adhesive layer. Then attach the release paper. The release paper can be completely attached to the surface of the adhesive layer. After drying and sterilization, a medical dressing is obtained.
[0058] Performance testing 1. Healing performance test Finished medical dressings were prepared by the preparation methods of Examples 1-9 and Comparative Example 1, respectively. 50 adult male rabbits with a weight difference of less than 0.5 kg were taken and divided into 10 groups, 5 rabbits in each group. A wound was scratched on the inner thigh of the rabbit, and the wound was 1 cm long, 0.2 cm wide and 0.6 cm deep. Finished medical dressings were prepared for the 10 groups of rabbits by the preparation methods of Examples 1-9 and Comparative Example 1, respectively. The length, width and height of the medical dressing were all 3 cm. The release paper on the medical dressing was peeled off, and the dressing was adhered to the wound surface so that the dressing completely covered the wound. The dressing was changed every 24 hours for the first 3 days, and changed every 2 days from the 3rd day to the 8th day. The dressing was changed every 4 days starting from the 8th day, and the time when the wound was completely healed was recorded.
[0059] 2. Antibacterial and antimicrobial performance testing Finished medical dressings were prepared by the preparation methods of Examples 1-9 and Comparative Example 1, respectively. 50 adult male rabbits with a weight difference of less than 0.5 kg were divided into 10 groups, 5 rabbits in each group, and wounds were scratched on the inner thighs of the rabbits. The wound was infiltrated with 2×10 5 CFU / ml of Staphylococcus epidermidis suspension, the wound was 1 cm long, 0.2 cm wide, and 0.6 cm deep; Tear off the release paper on the surface of the medical dressing, and then stick the dressing to the wound. After the dressing is applied for 48 hours, remove the dressing and test the bacterial content on the epidermis; and test the bacterial content at a depth of 0.5 cm from the wound and record the data; Tear off the release paper on the surface of the medical dressing and stick the dressing to the wound. After the dressing has been used for 5 days, test the bacteria on the epidermis again and record the data.
[0060] 3. Sensitive performance testing Finished medical dressings were prepared by the preparation methods of Examples 1-3 and Comparative Example 1, respectively. 50 adult male rabbits with a weight difference of less than 0.5 kg were taken and divided into 10 groups, 5 rabbits in each group. A wound was scratched on the inner thigh of the rabbit, with a length of 1 cm, a width of 0.2 cm, and a depth of 0.6 cm. The release paper on the medical dressing was peeled off, and the dressing was adhered to the wound surface so that the dressing completely covered the wound. After 24 hours of use, the redness, swelling and sensitivity of the rabbit skin surface were scored, and the scoring criteria were as follows: no redness, swelling and no irritation 10 points → severe redness, swelling, and severe sensitivity 1 point, and the data was recorded.
[0061] 4. Scar detection Finished medical dressings were prepared by the preparation methods of Examples 1-9 and Comparative Example 1, respectively. 50 adult male rabbits with a weight difference of less than 0.5 kg were taken and divided into 10 groups, with 5 rabbits in each group. Second-degree burn wounds were made on the backs of the rabbits, with a length of 2 cm and a width of 1.5 cm. The release paper on the medical dressing was peeled off, and the dressing was adhered to the wound surface so that the dressing completely covered the wound. The dressing was changed once a day for the first 3 days, and changed every two days from the 3rd day to the 8th day. After the 8th day, the dressing was changed every 4 days, and the grade of the scar area after the wound healed was recorded. The grade standards are as follows: Grade 0 - the scar area is less than 5% of the original area; Grade 1 - the scar area is 5%-10% of the original area (excluding 10%); Grade 2 - the scar area is 10%-20% of the original area (excluding 30%); Grade 3 - the scar area is 20%-50% of the original area (excluding 50%); Grade 4 - the scar area is 50%-80% of the original area (excluding 80%); Grade 5 - the scar area is greater than 80% of the original area.
[0062] Table 1 Performance test table (“ / ” in the table means that the corresponding embodiment or comparative example did not test the item, so there is no data) It can be seen from Examples 1-3 and Table 1 that the medical dressing prepared in the present application has the effect of promoting healing, and can kill bacteria in the epidermis and deep in the wound. It still has good bactericidal and antibacterial effects after long-term use, is not prone to sensitivity problems, and can also control scar formation.
[0063] Combining Example 1 and Examples 4-9 and Table 1, it can be seen that polycaprolactone-modified chitosan fiber is not added during the preparation of the polyurethane foam layer in Example 4. Compared with Example 1, the wound healing time of the medical dressing prepared in Example 4 is longer than that in Example 1, and the bacterial content is greater than that in Example 1, and the scar area is greater than that in Example 1; this indicates that polycaprolactone makes the surface of the chitosan fiber smooth, and the repulsive effect between the positive charge of the chitosan fiber and the positive charge of the copper ion promotes the migration and movement of the copper ions, and the copper ions migrate toward the skin surface, ensuring the antibacterial and bactericidal effects of the copper ions on the skin surface and deep inside. Even if the dressing is used for a long time, it can still have a bactericidal effect, and the healing-promoting effect of the copper ions makes the medical dressing have the advantages of long-term antibacterial and antibacterial properties, promotes wound healing, and is not easy to produce scars.
[0064] When preparing the polycaprolactone-modified chitosan fiber in the polyurethane foam layer of Example 5, the chitosan fiber was replaced by glass fiber of equal mass. Compared with Example 1, the wound healing time of the medical dressing prepared in Example 5 was longer than that in Example 1, and the bacterial content was greater than that in Example 1, and the scar area was greater than that in Example 1; this indicates that the glass fiber does not have a positive charge and cannot achieve charge repulsion, thereby promoting the migration of copper ions toward the skin surface, and cooperating with the negative charge of the bacteria on the skin surface, the negative charge of the hydroxyapatite nanowires, and the negative charge of the glutamate solution, further ensuring the antibacterial and bactericidal effects of the dressing on the wound surface, thereby promoting wound healing.
[0065] In the preparation process of the polyurethane foam layer of Example 6, no pore-forming agent was added. In the polyurethane foam layer of Example 7, the pore-forming agent was sodium bicarbonate particles. Compared with Example 1, the wound healing time of the medical dressings prepared in Examples 6 and 7 was longer than that in Example 1, and the bacterial content was greater than that in Example 1, and the scar area was greater than that in Example 1; this indicates that the carbon dioxide gas generated by the thermal decomposition of sodium bicarbonate further increases the porosity of the polyurethane foam layer and the content of copper ions, which facilitates the dressing to exert its long-term antibacterial and bactericidal effects, and the chitosan quaternary ammonium salt and chitosan fiber are positively charged, which repel the positive charge of copper ions. During the use of the dressing, the copper ions are convenient to migrate toward the skin surface under the diversion effect of the fibers and pores, thereby achieving the antibacterial and bactericidal effect on the skin surface, ensuring the long-term bactericidal and antibacterial effects of the dressing, and promoting wound healing.
[0066] In Example 8, no sodium alginate solution was added to the glutamate solution. Compared with Example 1, the wound healing time of the medical dressing prepared in Example 8 was longer than that in Example 1, and the bacterial content was greater than that in Example 1, and the scar area was greater than that in Example 1; this indicates that the glutamate aqueous solution and the sodium alginate solution are matched, and the viscosity of the sodium alginate solution is utilized to improve the viscosity of the glutamate solution, so that the hydroxyapatite nanowires are adhered to the surface of the polyurethane foam layer. Glutamic acid contains amino and carboxyl groups, and sodium alginate contains carboxyl groups. The flexible folding effect of the hydroxyapatite nanowires and the hydroxyl groups facilitate the formation of an interwoven network on the surface of the polyurethane foam layer. The glutamate, sodium alginate and hydroxyapatite nanowires in the interwoven network have no irritating effect on the skin surface, are not prone to allergies after contacting the skin, and are stable. The negative charge in the interwoven network can gradually cause the copper ions to migrate toward the interwoven network. The copper ions are highly stable in the interwoven network and are not easy to irritate the skin. They can efficiently and for a long time exert bactericidal and antibacterial effects on the skin surface, and can also promote wound healing.
[0067] In the preparation process of Example 9, the hydroxyapatite nanowires were not immersed in a citric acid solution. Compared with Example 1, the wound healing time of the medical dressing prepared in Example 9 was longer than that in Example 1, and the bacterial content was greater than that in Example 1, and the scar area was greater than that in Example 1; this indicates that after being treated with a citric acid solution, the negative charge content can be increased, thereby facilitating the adsorption of copper ions to reach the skin surface, and cooperating with the carboxyl group in the citric acid to further improve the stability and adsorption effect of the interwoven network, facilitating the adsorption of tissue fluid, and achieving antibacterial and bactericidal effects, thereby improving the long-term antibacterial effect of the dressing, promoting wound healing while minimizing the problem of wound infection.
[0068] Combining Example 1 and Comparative Example 1 and Table 1, it can be seen that the medical dressing of Comparative Example 1 is not treated with hydroxyapatite nanowires and glutamic acid solution. Compared with Example 1, the wound healing time of the medical dressing prepared in Comparative Example 1 is longer than that of Example 1, and the bacterial content is greater than that of Example 1, the scar area is greater than that of Example 1, and the sensitivity score is lower than that of Example 1; this indicates that the interwoven network of hydroxyapatite nanowires and glutamic acid solution can buffer the irritation of copper ions to the skin surface, so that allergic reactions such as skin redness and swelling are not likely to occur, and can deeply sterilize, and the sterilization effect deep in the wound is better after the dressing is used for a long time.
[0069] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed. However, as long as it is within the scope of the claims of the present application, it shall be protected by the patent law.
Claims
1. A method for preparing a medical dressing containing copper ions, It is characterized in that The following steps are included: S1. Evenly spray adhesive on the surface of the polyurethane film to obtain an adhesive layer; S2, immersing the polyurethane foam layer in a copper citrate solution, then taking out the polyurethane foam layer, and freeze-drying it to obtain an adsorption layer; S3, bonding one side of the adsorption layer to the surface of the adhesive layer, spraying glutamic acid solution evenly on the other side of the adsorption layer, and then bonding the hydroxyapatite nanowires, and finally pasting the release paper, drying, sterilizing, and obtaining a medical dressing.
2. A method for preparing a medical dressing containing copper ions according to claim 1, Features: The polyurethane foam layer comprises the following raw materials in parts by weight: 80-100 parts of waterborne polyurethane prepolymer, 20-30 parts of isocyanate, 2-5 parts of foaming agent, 1-5 parts of polycaprolactone modified chitosan fiber, 2-8 parts of surfactant, 1-3 parts of pore-forming agent and 100-240 parts of water.
3. A method for preparing a medical dressing containing copper ions according to claim 2, Features: The polycaprolactone modified chitosan fiber is prepared by the following method: The polycaprolactone solution is weighed at a mass ratio of 1:1.5-2.5 and sprayed uniformly on the surface of the chitosan fiber, and then dispersed and dried to obtain a finished product.
4. A method for preparing a medical dressing containing copper ions according to claim 2, Features: The pore-forming agent is prepared by the following method: Polyethylene glycol ethanol solution is uniformly sprayed on the surface of chitosan quaternary ammonium salt particles, then sodium bicarbonate particles are bonded, and then dried and dispersed to prepare a pore-forming agent; the mass ratio of chitosan quaternary ammonium salt particles to polyethylene glycol ethanol solution and sodium bicarbonate particles is 1:0.2-0.4:0.5-1.
5. A method for preparing a medical dressing containing copper ions according to claim 1, Features: The glutamate solution consists of a glutamate aqueous solution and a sodium alginate solution in a mass ratio of 1:0.1-0.
2.
6. A method for preparing a medical dressing containing copper ions according to claim 1, Features: The hydroxyapatite nanowires are prepared by soaking hydroxyapatite nanowire filaments in a citric acid solution and then drying them.
7. A method for preparing a medical dressing containing copper ions according to claim 1, It is characterized in that The adhesive in S1 is a silicone adhesive.
8. A method for preparing a medical dressing containing copper ions according to claim 1, It is characterized in that The copper citrate solution in S2 is a copper citrate aqueous solution with a mass fraction of 1-8%.
9. A method for preparing a medical dressing containing copper ions according to claim 1, It is characterized in that The pressure of the immersion treatment in S2 is 0.2-0.5 MPa.
10. A method for preparing a medical dressing containing copper ions according to claim 1, It is characterized in that The freeze-drying temperature in S2 is -40°C to -20°C, and the freeze-drying time is 12-24h.
